TDC
PROF

Thompson Davis & Co’s Profound Medical PROF Stock Holding History

Thompson Davis & Co’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.44M Buy
216,535
+750
+0.3% +$5.04K 0.86% 18
2026
Q1 		$1.4M Sell
215,785
-950
-0.4% -$6.56K 0.93% 14
2025
Q4 		$1.71M Buy
216,735
+8,015
+4% +$51.5K 1.02% 13
2025
Q3 		$1.02M Sell
208,720
-1,775
-0.8% -$9.06K 0.63% 27
2025
Q2 		$1.24M Buy
210,495
+6,645
+3% +$35.1K 0.85% 17
2025
Q1 		$1.19M Buy
203,850
+21,555
+12% +$149K 0.94% 14
2024
Q4 		$1.37M Buy
182,295
+80,395
+79% +$617K 0.88% 11
2024
Q3 		$811K Buy
101,900
+27,100
+36% +$245K 0.6% 26
2024
Q2 		$628K Buy
74,800
+6,150
+9% +$49.6K 0.54% 30
2024
Q1 		$586K Buy
68,650
+225
+0.3% +$1.88K 0.4% 27
2023
Q4 		$581K Sell
68,425
-17,950
-21% -$171K 0.49% 23
2023
Q3 		$881K Sell
86,375
-95
-0.1% -$985 1.09% 17
2023
Q2 		$1.12M Buy
86,470
+10,875
+14% +$135K 1.27% 13
2023
Q1 		$702K Buy
75,595
+4,300
+6% +$49.8K 0.92% 20
2022
Q4 		$776K Buy
71,295
+50,709
+246% +$277K 1.1% 15
2022
Q3 		$83K Sell
20,586
-3,826
-16% -$25.8K 0.11% 69
2022
Q2 		$178K Sell
24,412
-7,287
-23% -$57.6K 0.29% 69
2022
Q1 		$285K Sell
31,699
-1,439
-4% -$13.9K 0.35% 62
2021
Q4 		$374K Buy
+33,138
New +$414K 0.31% 59

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $349M AUM 28.06% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $476M AUM
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Thompson Davis & Co's PROF Position: Q2 2026 in Review

Thompson Davis & Co increased its Profound Medical (PROF) stake by 0.35% in Q2 2026, buying an estimated $5.04K and bringing the position to 216,535 shares worth $1.44M. The position accounts for 0.86% of the portfolio, ranked #18.

Thompson Davis & Co first reported a position in PROF in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.71M in Q4 2025. 56 funds tracked by Wall St. Rank hold PROF as of Q2 2026.

  • Thompson Davis & Co held 216,535 shares of Profound Medical worth $1.44M as of Q2 2026.
  • Thompson Davis & Co bought 750 Profound Medical shares in Q2 2026, an estimated $5.04K.
  • Profound Medical made up 0.86% of Thompson Davis & Co's portfolio in Q2 2026, its #18 holding.
  • Thompson Davis & Co first reported a position in Profound Medical in Q4 2021 and has held it in 19 quarters since.
  • Thompson Davis & Co's Profound Medical position peaked at $1.71M in Q4 2025.
  • 56 funds tracked by Wall St. Rank held Profound Medical as of Q2 2026.

Based on Thompson Davis & Co's 13F filing for Q2 2026, filed 29 Jul 2026.